Patient Reported Experiences With Sparing ExteRnal Oblique Fascia Vs Standard Inguinal OrchiEctomy

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to evaluate the difference in patient-reported postoperative outcomes between two standard-of-care surgical techniques for radical orchiectomy (inguinal orchiectomy versus external oblique fascia sparing orchiectomy) for treatment of patients with suspected testicular malignancy. The main questions it aims to answer are: 1. Does sparing the external oblique fascia during orchiectomy reduce pain after surgery? 2. Is there a difference in narcotic consumption after surgery? 3. Is there a difference in neuropathic pain after surgery? 4. Is there a difference in complications after surgery?

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Participants undergoing radical orchiectomy for suspected testicular malignancy

• Testicular malignancy can be germ cell tumor or non germ cell tumors, including paratesticular tumors as long as a radical orchiectomy is planned

• Participants over 18 years of age who can provide informed consent

• Participants not currently using opiates for another reason

• Regional and metastatic patients are allowed, as long as participant does not require opiates for pain related to metastatic disease

• No contraindication for participant to receive standardized medication pathway in the peri-operative period.

Locations
United States
California
Loma Linda University
RECRUITING
Loma Linda
Contact Information
Primary
Muhannad Alsyouf, MD
Malsyouf@llu.edu
9095584000
Backup
Brian Hu, MD
Bhu@llu.edu
9095584000
Time Frame
Start Date: 2025-05
Estimated Completion Date: 2029-09
Participants
Target number of participants: 80
Treatments
Active_comparator: Radical inguinal orchiectomy
Active_comparator: Radical external oblique fascia sparing orchiectomy
Related Therapeutic Areas
Sponsors
Leads: Loma Linda University

This content was sourced from clinicaltrials.gov